BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 17988337)

  • 1. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
    Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
    Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
    Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
    Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
    Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease.
    Morita K; Tsukita S; Miyachi Y
    Br J Dermatol; 2004 Aug; 151(2):328-34. PubMed ID: 15327539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
    Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
    J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of MCM2 in nonmelanoma epithelial skin cancers.
    Abdou AG; Elwahed MG; Serag El-Dien MM; Eldien DS
    Am J Dermatopathol; 2014 Dec; 36(12):959-64. PubMed ID: 24936676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
    Mihailovici MS; Teleman S; Ungureanu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders.
    Gambichler T; Bischoff S; Bechara FG; Altmeyer P; Kreuter A
    J Dermatol Sci; 2008 Feb; 49(2):125-32. PubMed ID: 17826963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased level of c-erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinoma.
    Ahmed NU; Ueda M; Ichihashi M
    Br J Dermatol; 1997 Jun; 136(6):908-12. PubMed ID: 9217824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical alterations in basement membrane components in skin cancer].
    Oguro K
    Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):105-13. PubMed ID: 2072578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
    J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nuclear DNA content in the cells of squamous cell carcinoma and Bowen's disease. II. A study on DNA contents of deeply invaded cells in comparison with non-invading cells at the upper dermis].
    Toyoshima H
    Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):835-8. PubMed ID: 2232291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P16(INK4A) expression in Bowen's disease and Bowenoid papulosis.
    Auepemkiate S; Thongsuksai P; Boonyaphiphat P
    J Med Assoc Thai; 2006 Sep; 89(9):1460-5. PubMed ID: 17100385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.